{"id":8466,"date":"2024-10-21T09:48:15","date_gmt":"2024-10-21T14:48:15","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=8466"},"modified":"2024-10-29T09:04:15","modified_gmt":"2024-10-29T14:04:15","slug":"fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/","title":{"rendered":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP)"},"content":{"rendered":"\n<p>Mejorar la disponibilidad de medicamentos innovadores en Am\u00e9rica Latina es una prioridad para todos los actores del sistema de salud, especialmente los formuladores de pol\u00edticas, los fabricantes farmac\u00e9uticos y los pacientes. Desde 2004, la asociaci\u00f3n de la industria farmac\u00e9utica<br>europea (EFPIA) aplica el indicador W.A.I.T. para Pacientes (por sus siglas en ingl\u00e9s, Waiting to Access Innovative Therapies &#8211; En espera de recibir terapias innovadoras), que permite a las partes interesadas medir la tasa de disponibilidad de medicamentos innovadores en 37 pa\u00edses europeos. Este estudio ha sido replicado para comprender la tasa de disponibilidad en ocho pa\u00edses de Am\u00e9rica Latina.<\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"author":24,"parent":0,"template":"","ano":[88],"idioma":[31],"etiquetas-publicacion":[172,156,28,173],"categoria-publicacion":[29],"class_list":["post-8466","publicaciones","type-publicaciones","status-publish","hentry","ano-88","idioma-espanol","etiquetas-publicacion-acceso","etiquetas-publicacion-latam","etiquetas-publicacion-medicamentos-innovadores","etiquetas-publicacion-wait","categoria-publicacion-reporte"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP) - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP)\" \/>\n<meta property=\"og:description\" content=\"Mejorar la disponibilidad de medicamentos innovadores en Am\u00e9rica Latina es una prioridad para todos los actores del sistema de salud, especialmente los formuladores de pol\u00edticas, los fabricantes farmac\u00e9uticos y los pacientes. Desde 2004, la asociaci\u00f3n de la industria farmac\u00e9uticaeuropea (EFPIA) aplica el indicador W.A.I.T. para Pacientes (por sus siglas en ingl\u00e9s, Waiting to Access Innovative [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-29T14:04:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\\\/\",\"name\":\"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP) - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2024-10-21T14:48:15+00:00\",\"dateModified\":\"2024-10-29T14:04:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP) - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/","og_locale":"pt_BR","og_type":"article","og_title":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP)","og_description":"Mejorar la disponibilidad de medicamentos innovadores en Am\u00e9rica Latina es una prioridad para todos los actores del sistema de salud, especialmente los formuladores de pol\u00edticas, los fabricantes farmac\u00e9uticos y los pacientes. Desde 2004, la asociaci\u00f3n de la industria farmac\u00e9uticaeuropea (EFPIA) aplica el indicador W.A.I.T. para Pacientes (por sus siglas en ingl\u00e9s, Waiting to Access Innovative [&hellip;]","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/","og_site_name":"FIFARMA","article_modified_time":"2024-10-29T14:04:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/","url":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/","name":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP) - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2024-10-21T14:48:15+00:00","dateModified":"2024-10-29T14:04:15+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-w-a-i-t-indicator-2024-america-latina-esp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Am\u00e9rica Latina (ESP)"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/8466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=8466"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=8466"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=8466"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=8466"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=8466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}